Dr. Elaine Wong-Ho will review homologous recombination deficiency (HRD) assessment with the Oncomine Comprehensive Assay Plus and review current HRD studies from leading experts in diagnostics. New ...
Clinical laboratories worldwide are implementing various targeted panels to identify cancer genomic variants and ultimately improve patient outcomes. As most of the panels and NGS platforms are ...
Recipients’ research advances future development of oncology diagnostics, the impact of DNA quality on ovarian cancer outcomes and molecular diagnosis with T cell receptor convergence CARLSBAD, Calif.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results